Oncolytic Virus Market Size, Share, Growth, and Industry Analysis, By Type (Herpes Simplex Virus (HSV), Adenovirus, Vaccinia virus, Newcastle Disease Virus, Reovirus, Measles Virus), By Application (Hospitals & Clinics, Cancer Research Institutes, Ambulatory Surgical Centers, Others), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Oncolytic Virus Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Oncolytic Virus Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Oncolytic Virus Business Mode and Production Process
2.3.1 Oncolytic Virus Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Oncolytic Virus Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Oncolytic Virus
2.4.2 Raw Material Cost of Oncolytic Virus
2.4.3 Labor Cost of Oncolytic Virus
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Oncolytic Virus Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Oncolytic Virus Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Oncolytic Virus Price by Manufacturer (2021-2026)
4.4 Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Oncolytic Virus, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Oncolytic Virus, Product Offered and Application
4.7 Oncolytic Virus Market Competitive Situation and Trends
4.7.1 Oncolytic Virus Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Oncolytic Virus Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Oncolytic Virus Market Historical Development by Geographic Region (2021-2026)
5.1 Global Oncolytic Virus Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Oncolytic Virus Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Oncolytic Virus Market Status by Country (2021-2026)
5.3.1 North America Oncolytic Virus Sales Volume by Country (2021-2026)
5.3.2 North America Oncolytic Virus Revenue by Country (2021-2026)
5.3.3 United States Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Oncolytic Virus Market Status by Country (2021-2026)
5.4.1 Europe Oncolytic Virus Sales Volume by Country (2021-2026)
5.4.2 Europe Oncolytic Virus Revenue by Country (2021-2026)
5.4.3 Germany Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Oncolytic Virus Market Status by Country (2021-2026)
5.5.1 Asia Pacific Oncolytic Virus Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Oncolytic Virus Revenue by Country (2021-2026)
5.5.3 China Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Oncolytic Virus Market Status by Country (2021-2026)
5.6.1 Latin America Oncolytic Virus Sales Volume by Country (2021-2026)
5.6.2 Latin America Oncolytic Virus Revenue by Country (2021-2026)
5.6.3 Mexico Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Oncolytic Virus Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Oncolytic Virus Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Oncolytic Virus Revenue by Country (2021-2026)
5.7.3 GCC Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Oncolytic Virus Sales Volume, Revenue and Growth (2021-2026)

6 Global Oncolytic Virus Market Historical Development by Product Type (2021-2026)
6.1 Oncolytic Virus Definition by Type
6.2 Global Oncolytic Virus Historical Sales Volume by Product Type (2021-2026)
6.3 Global Oncolytic Virus Historical Revenue by Product Type (2021-2026)
6.4 Global Oncolytic Virus Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Herpes Simplex Virus (HSV) (2021-2026)
6.5.2 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Adenovirus (2021-2026)
6.5.3 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Vaccinia virus (2021-2026)
6.5.4 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Newcastle Disease Virus (2021-2026)
6.5.5 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Reovirus (2021-2026)
6.5.6 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Measles Virus (2021-2026)

7 Global Oncolytic Virus Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Oncolytic Virus Historical Sales Volume by End User (2021-2026)
7.3 Global Oncolytic Virus Historical Revenue by End User (2021-2026)
7.4 Global Oncolytic Virus Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Hospitals & Clinics (2021-2026)
7.5.2 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Cancer Research Institutes (2021-2026)
7.5.3 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Ambulatory Surgical Centers (2021-2026)
7.5.4 Global Oncolytic Virus Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

8 Leading Companies Profiles
8.1 CG Oncology, Inc.
8.1.1 CG Oncology, Inc. Corporation Information
8.1.2 CG Oncology, Inc. - Oncolytic Virus Product Portfolio and Specification
8.1.3 CG Oncology, Inc. Performance Analysis (2021-2026)
8.1.4 CG Oncology, Inc. Business and Markets Served
8.1.5 CG Oncology, Inc. Recent Developments
8.2 Kissei Pharmaceutical Co. Ltd.
8.2.1 Kissei Pharmaceutical Co. Ltd. Corporation Information
8.2.2 Kissei Pharmaceutical Co. Ltd. - Oncolytic Virus Product Portfolio and Specification
8.2.3 Kissei Pharmaceutical Co. Ltd. Performance Analysis (2021-2026)
8.2.4 Kissei Pharmaceutical Co. Ltd. Business and Markets Served
8.2.5 Kissei Pharmaceutical Co. Ltd. Recent Developments
8.3 Genelux Corporation
8.3.1 Genelux Corporation Corporation Information
8.3.2 Genelux Corporation - Oncolytic Virus Product Portfolio and Specification
8.3.3 Genelux Corporation Performance Analysis (2021-2026)
8.3.4 Genelux Corporation Business and Markets Served
8.3.5 Genelux Corporation Recent Developments
8.4 Binhui Biopharmaceutical Co. Ltd.
8.4.1 Binhui Biopharmaceutical Co. Ltd. Corporation Information
8.4.2 Binhui Biopharmaceutical Co. Ltd. - Oncolytic Virus Product Portfolio and Specification
8.4.3 Binhui Biopharmaceutical Co. Ltd. Performance Analysis (2021-2026)
8.4.4 Binhui Biopharmaceutical Co. Ltd. Business and Markets Served
8.4.5 Binhui Biopharmaceutical Co. Ltd. Recent Developments
8.5 Amgen, Inc.
8.5.1 Amgen, Inc. Corporation Information
8.5.2 Amgen, Inc. - Oncolytic Virus Product Portfolio and Specification
8.5.3 Amgen, Inc. Performance Analysis (2021-2026)
8.5.4 Amgen, Inc. Business and Markets Served
8.5.5 Amgen, Inc. Recent Developments
8.6 Sorrento Therapeutics, Inc.
8.6.1 Sorrento Therapeutics, Inc. Corporation Information
8.6.2 Sorrento Therapeutics, Inc. - Oncolytic Virus Product Portfolio and Specification
8.6.3 Sorrento Therapeutics, Inc. Performance Analysis (2021-2026)
8.6.4 Sorrento Therapeutics, Inc. Business and Markets Served
8.6.5 Sorrento Therapeutics, Inc. Recent Developments
8.7 Oncorus, Inc.
8.7.1 Oncorus, Inc. Corporation Information
8.7.2 Oncorus, Inc. - Oncolytic Virus Product Portfolio and Specification
8.7.3 Oncorus, Inc. Performance Analysis (2021-2026)
8.7.4 Oncorus, Inc. Business and Markets Served
8.7.5 Oncorus, Inc. Recent Developments
8.8 Creative Biolabs
8.8.1 Creative Biolabs Corporation Information
8.8.2 Creative Biolabs - Oncolytic Virus Product Portfolio and Specification
8.8.3 Creative Biolabs Performance Analysis (2021-2026)
8.8.4 Creative Biolabs Business and Markets Served
8.8.5 Creative Biolabs Recent Developments
8.9 Shanghai Sunway Biotech Co. Ltd.
8.9.1 Shanghai Sunway Biotech Co. Ltd. Corporation Information
8.9.2 Shanghai Sunway Biotech Co. Ltd. - Oncolytic Virus Product Portfolio and Specification
8.9.3 Shanghai Sunway Biotech Co. Ltd. Performance Analysis (2021-2026)
8.9.4 Shanghai Sunway Biotech Co. Ltd. Business and Markets Served
8.9.5 Shanghai Sunway Biotech Co. Ltd. Recent Developments
8.10 Siga Technologies
8.10.1 Siga Technologies Corporation Information
8.10.2 Siga Technologies - Oncolytic Virus Product Portfolio and Specification
8.10.3 Siga Technologies Performance Analysis (2021-2026)
8.10.4 Siga Technologies Business and Markets Served
8.10.5 Siga Technologies Recent Developments
8.11 Adlai Nortye Biopharma Co. Ltd.
8.11.1 Adlai Nortye Biopharma Co. Ltd. Corporation Information
8.11.2 Adlai Nortye Biopharma Co. Ltd. - Oncolytic Virus Product Portfolio and Specification
8.11.3 Adlai Nortye Biopharma Co. Ltd. Performance Analysis (2021-2026)
8.11.4 Adlai Nortye Biopharma Co. Ltd. Business and Markets Served
8.11.5 Adlai Nortye Biopharma Co. Ltd. Recent Developments
8.12 Replimune, Inc.
8.12.1 Replimune, Inc. Corporation Information
8.12.2 Replimune, Inc. - Oncolytic Virus Product Portfolio and Specification
8.12.3 Replimune, Inc. Performance Analysis (2021-2026)
8.12.4 Replimune, Inc. Business and Markets Served
8.12.5 Replimune, Inc. Recent Developments
8.13 TILT Biotherapeutics
8.13.1 TILT Biotherapeutics Corporation Information
8.13.2 TILT Biotherapeutics - Oncolytic Virus Product Portfolio and Specification
8.13.3 TILT Biotherapeutics Performance Analysis (2021-2026)
8.13.4 TILT Biotherapeutics Business and Markets Served
8.13.5 TILT Biotherapeutics Recent Developments
8.14 Daiichi Sankyo Co., Ltd.
8.14.1 Daiichi Sankyo Co., Ltd. Corporation Information
8.14.2 Daiichi Sankyo Co., Ltd. - Oncolytic Virus Product Portfolio and Specification
8.14.3 Daiichi Sankyo Co., Ltd. Performance Analysis (2021-2026)
8.14.4 Daiichi Sankyo Co., Ltd. Business and Markets Served
8.14.5 Daiichi Sankyo Co., Ltd. Recent Developments
8.15 Merck & Co., Inc. (Viralytics Ltd.)
8.15.1 Merck & Co., Inc. (Viralytics Ltd.) Corporation Information
8.15.2 Merck & Co., Inc. (Viralytics Ltd.) - Oncolytic Virus Product Portfolio and Specification
8.15.3 Merck & Co., Inc. (Viralytics Ltd.) Performance Analysis (2021-2026)
8.15.4 Merck & Co., Inc. (Viralytics Ltd.) Business and Markets Served
8.15.5 Merck & Co., Inc. (Viralytics Ltd.) Recent Developments

9 Global Oncolytic Virus Market Forecast by Product Type and End User (2026-2034)
9.1 Global Oncolytic Virus Market Forecast by Product Type (2026-2034)
9.1.1 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Herpes Simplex Virus (HSV) (2026-2034)
9.1.2 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Adenovirus (2026-2034)
9.1.3 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Vaccinia virus (2026-2034)
9.1.4 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Newcastle Disease Virus (2026-2034)
9.1.5 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Reovirus (2026-2034)
9.1.6 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Measles Virus (2026-2034)
9.2 Global Oncolytic Virus Market Forecast by End User (2026-2034)
9.2.1 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Hospitals & Clinics (2026-2034)
9.2.2 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Cancer Research Institutes (2026-2034)
9.2.3 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Ambulatory Surgical Centers (2026-2034)
9.2.4 Global Oncolytic Virus Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)

10 Global Oncolytic Virus Market Forecast by Geographic Region (2026-2034)
10.1 Global Oncolytic Virus Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Oncolytic Virus Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer